Cardiovascular risk factors in patients with type 2 diabetes -: Do we follow the guidelines?

被引:30
|
作者
del Cañizo-Gómez, FJ
Moreira-Andrés, MN
机构
[1] Hosp Virgen Torre, Endocrinol Unit, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Endocrinol, Madrid 28041, Spain
关键词
type 2 diabetes mellitus; cardiovascular risk factors; coronary artery disease; hypertension; dyslipidaemia;
D O I
10.1016/j.diabres.2003.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the degree of control of modifiable cardiovascular risk factors (CRFs) in type 2 diabetic patients. Study design and methods: Cross-sectional study in 501 patients with type 2 diabetes mellitus. The following parameters were used to define optimal control: glycated haemoglobin (HbA(1c)) <7.0%, fasting plasma glucose (FPG) <7.2 mmol/l, postprandial capillary glucose (PCG) <10.0mmol/l, high-density lipoprotein cholesterol (HDL-C) >1,1 mmol/l, low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/l, triglyceride levels (TG) < 1.7 mmol/l, systolic blood pressure (SBP) < 130 mmHg, diastolic blood pressure (DBP) <80 mmHg, body mass index (BMI) <25kg/m(2), waist circumference (WC) <88cm in women and < 102 cm in men, and current non-smoking status. The use of various cardioprotective medications was also evaluated. Results: Mean ( +/-S.D.) age was 65.4 +/- 11.9 years, 218 (44%) were male. Ninety-six (19%) met coronary artery disease (CAD). Two hundred seven patients (41%) had an HbA(1c) <7.0%, 134 (27%) a FPG <7.2 mmol/l and 231 of 353 (65%) a PCG < 10.0 mmol/l. Only 206 (41%) achieved an LDL-C <2.6 mmol/l, but 370 (74%) and 308 (62%) reached an HDL-C > 1.1 mmol/l and a TG levels < 1.7 mmol/l, respectively. In 359 (72%) patients DBP was < 80 mmHg, but in only 136 (27%) was SBP < 130 mm-Hg. Sixty four (13%) achieved a BMI <25 kg/m(2), and 420 (84%) were non-smokers. Forty three (15%) women and 104 (48%) men had a WC <88 or <102 cm, respectively. None of the patients had optimal control of all CRFs. Conclusions: These data demonstrate poor control of modifiable CRFs in the population studied, and support the need for great effort to achieve the recommended goals. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 50 条
  • [21] Pharmacologic Treatment in Dialysis Patients Hospitalized for Cardiovascular Reasons: Do We Follow the Guidelines?
    Tomaszuk-Kazberuk, Anna
    Kozuch, Marcin
    Malyszko, Jolanta
    Bachorzewska-Gajewska, Hanna
    Dobrzycki, Slawomir
    Musial, Wlodzimierz J.
    RENAL FAILURE, 2013, 35 (02) : 235 - 242
  • [22] Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison
    Kelsey, Michelle D.
    Nelson, Adam J.
    Green, Jennifer B.
    Granger, Christopher B.
    Peterson, Eric D.
    McGuire, Darren K.
    Pagidipati, Neha J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (18) : 1849 - 1857
  • [23] Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care.: The gap between guidelines and reality in Spain
    Orozco-Beltran, D.
    Gil-Guillen, V. F.
    Quirce, F.
    Navarro-Perez, J.
    Pineda, M.
    Gomez-de-la-Camara, A.
    Pita, S.
    Diez-Espino, J.
    Mateos, J.
    Merino, J.
    Serrano-Rios, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (06) : 909 - 915
  • [24] Cardiovascular risk in patients with type 2 diabetes
    Parmar, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (09) : 1160 - 1160
  • [25] Clustering of cardiovascular risk factors in type 2 diabetes
    Liu, Jun
    Liu, Fang
    Chen, Ying
    Xu, Dong-Li
    Yao, Qing-Gu
    Fudan University Journal of Medical Sciences, 2004, 31 (02): : 171 - 175
  • [26] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [27] Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes Epidemiology and risk factors
    Giorda, Carlo B.
    Avogaro, Angelo
    Maggini, Marina
    Lombardo, Flavia
    Mannucci, Edoardo
    Turco, Salvatore
    Alegiani, Stefania Spila
    Raschetti, Roberto
    Velussi, Mario
    Ferrannini, Ele
    DIABETES CARE, 2008, 31 (11) : 2154 - 2159
  • [28] Risk factors for cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients
    Semyatichko, E.
    Nemtsova, V.
    Feclina, I.
    JOURNAL OF NEUROLOGY, 2007, 254 : 110 - 110
  • [29] Electrocardiographic abnormalities and cardiovascular risk factors in patients with type 2 diabetes.
    Rodríguez-Morán, M
    Guerrero-Romero, F
    SALUD PUBLICA DE MEXICO, 1999, 41 (01): : 12 - 17
  • [30] THE ASSESSMENT OF THE ASSOCIATED CARDIOVASCULAR RISK FACTORS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES
    Tudorica, C.
    Vintila, A.
    Tudorica, S.
    Vintila, V.
    Bulei, C.
    Gurghean, A.
    JOURNAL OF HYPERTENSION, 2017, 35 : E96 - E96